163 related articles for article (PubMed ID: 16984060)
1. Economics of tandem mass spectrometry screening of neonatal inherited disorders.
Pandor A; Eastham J; Chilcott J; Paisley S; Beverley C
Int J Technol Assess Health Care; 2006; 22(3):321-6. PubMed ID: 16984060
[TBL] [Abstract][Full Text] [Related]
2. Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review.
Pandor A; Eastham J; Beverley C; Chilcott J; Paisley S
Health Technol Assess; 2004 Mar; 8(12):iii, 1-121. PubMed ID: 14982654
[TBL] [Abstract][Full Text] [Related]
3. Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis.
Venditti LN; Venditti CP; Berry GT; Kaplan PB; Kaye EM; Glick H; Stanley CA
Pediatrics; 2003 Nov; 112(5):1005-15. PubMed ID: 14595039
[TBL] [Abstract][Full Text] [Related]
4. The cost-effectiveness of expanding newborn screening for up to 21 inherited metabolic disorders using tandem mass spectrometry: results from a decision-analytic model.
Cipriano LE; Rupar CA; Zaric GS
Value Health; 2007; 10(2):83-97. PubMed ID: 17391418
[TBL] [Abstract][Full Text] [Related]
5. An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand.
Thiboonboon K; Leelahavarong P; Wattanasirichaigoon D; Vatanavicharn N; Wasant P; Shotelersuk V; Pangkanon S; Kuptanon C; Chaisomchit S; Teerawattananon Y
PLoS One; 2015; 10(8):e0134782. PubMed ID: 26258410
[TBL] [Abstract][Full Text] [Related]
6. Newborn screening with tandem mass spectrometry: examining its cost-effectiveness in the Wisconsin Newborn Screening Panel.
Insinga RP; Laessig RH; Hoffman GL
J Pediatr; 2002 Oct; 141(4):524-31. PubMed ID: 12378192
[TBL] [Abstract][Full Text] [Related]
7. Neonatal screening for inborn errors of metabolism: cost, yield and outcome.
Pollitt RJ; Green A; McCabe CJ; Booth A; Cooper NJ; Leonard JV; Nicholl J; Nicholson P; Tunaley JR; Virdi NK
Health Technol Assess; 1997; 1(7):i-iv, 1-202. PubMed ID: 9483160
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of universal newborn screening for medium chain acyl-CoA dehydrogenase deficiency in France.
Hamers FF; Rumeau-Pichon C
BMC Pediatr; 2012 Jun; 12():60. PubMed ID: 22681855
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of neonatal screening for medium chain acyl-CoA dehydrogenase deficiency: the homogeneous population of The Netherlands.
van der Hilst CS; Derks TG; Reijngoud DJ; Smit GP; TenVergert EM
J Pediatr; 2007 Aug; 151(2):115-20, 120.e1-3. PubMed ID: 17643759
[TBL] [Abstract][Full Text] [Related]
10. Newborn screening for inborn errors of metabolism: a systematic review.
Seymour CA; Thomason MJ; Chalmers RA; Addison GM; Bain MD; Cockburn F; Littlejohns P; Lord J; Wilcox AH
Health Technol Assess; 1997; 1(11):i-iv, 1-95. PubMed ID: 9483156
[TBL] [Abstract][Full Text] [Related]
11. Establishing core outcome sets for phenylketonuria (PKU) and medium-chain Acyl-CoA dehydrogenase (MCAD) deficiency in children: study protocol for systematic reviews and Delphi surveys.
Potter BK; Hutton B; Clifford TJ; Pallone N; Smith M; Stockler S; Chakraborty P; Barbeau P; Garritty CM; Pugliese M; Rahman A; Skidmore B; Tessier L; Tingley K; Coyle D; Greenberg CR; Korngut L; MacKenzie A; Mitchell JJ; Nicholls S; Offringa M; Schulze A; Taljaard M;
Trials; 2017 Dec; 18(1):603. PubMed ID: 29258568
[TBL] [Abstract][Full Text] [Related]
12. A systematic review of evidence for the appropriateness of neonatal screening programmes for inborn errors of metabolism.
Thomason MJ; Lord J; Bain MD; Chalmers RA; Littlejohns P; Addison GM; Wilcox AH; Seymour CA
J Public Health Med; 1998 Sep; 20(3):331-43. PubMed ID: 9793900
[TBL] [Abstract][Full Text] [Related]
13. Secondary analysis of economic data: a review of cost-benefit studies of neonatal screening for phenylketonuria.
Lord J; Thomason MJ; Littlejohns P; Chalmers RA; Bain MD; Addison GM; Wilcox AH; Seymour CA
J Epidemiol Community Health; 1999 Mar; 53(3):179-86. PubMed ID: 10396496
[TBL] [Abstract][Full Text] [Related]
14. Neonatal screening for medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in The Netherlands: the importance of enzyme analysis to ascertain true MCAD deficiency.
Derks TG; Boer TS; van Assen A; Bos T; Ruiter J; Waterham HR; Niezen-Koning KE; Wanders RJ; Rondeel JM; Loeber JG; Ten Kate LP; Smit GP; Reijngoud DJ
J Inherit Metab Dis; 2008 Feb; 31(1):88-96. PubMed ID: 18188679
[TBL] [Abstract][Full Text] [Related]
15. Screening for medium chain acyl-CoA dehydrogenase deficiency using electrospray ionisation tandem mass spectrometry.
Clayton PT; Doig M; Ghafari S; Meaney C; Taylor C; Leonard JV; Morris M; Johnson AW
Arch Dis Child; 1998 Aug; 79(2):109-15. PubMed ID: 9797589
[TBL] [Abstract][Full Text] [Related]
16. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency: performance improvement by monitoring a new ratio.
Hall PL; Wittenauer A; Hagar A
Mol Genet Metab; 2014 Dec; 113(4):274-7. PubMed ID: 25454677
[TBL] [Abstract][Full Text] [Related]
17. Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study.
Wilcken B; Haas M; Joy P; Wiley V; Chaplin M; Black C; Fletcher J; McGill J; Boneh A
Lancet; 2007 Jan; 369(9555):37-42. PubMed ID: 17208640
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy and cost-effectiveness of newborn screening for medium chain acyl-CoA dehydrogenase deficiency using tandem mass spectrometry.
Tran K; Banerjee S; Li H; Noorani HZ; Mensinkai S; Dooley K
Clin Biochem; 2007 Feb; 40(3-4):235-41. PubMed ID: 17222812
[TBL] [Abstract][Full Text] [Related]
19. Economic evaluation of neonatal screening for phenylketonuria and congenital hypothyroidism.
Geelhoed EA; Lewis B; Hounsome D; O'leary P
J Paediatr Child Health; 2005 Nov; 41(11):575-9. PubMed ID: 16398841
[TBL] [Abstract][Full Text] [Related]
20. Outcomes in pediatric studies of medium-chain acyl-coA dehydrogenase (MCAD) deficiency and phenylketonuria (PKU): a review.
Pugliese M; Tingley K; Chow A; Pallone N; Smith M; Rahman A; Chakraborty P; Geraghty MT; Irwin J; Tessier L; Nicholls SG; Offringa M; Butcher NJ; Iverson R; Clifford TJ; Stockler S; Hutton B; Paik K; Tao J; Skidmore B; Coyle D; Duddy K; Dyack S; Greenberg CR; Ghai SJ; Karp N; Korngut L; Kronick J; MacKenzie A; MacKenzie J; Maranda B; Mitchell JJ; Potter M; Prasad C; Schulze A; Sparkes R; Taljaard M; Trakadis Y; Walia J; Potter BK;
Orphanet J Rare Dis; 2020 Jan; 15(1):12. PubMed ID: 31937333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
